Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours (Q33248610)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours |
scientific article |
Statements
1 reference
Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours (English)
1 reference
M J A de Jonge
1 reference
H Dumez
1 reference
J Verweij
1 reference
S Yarkoni
1 reference
D Snyder
1 reference
D Lacombe
1 reference
S Marréaud
1 reference
T Yamaguchi
1 reference
C J A Punt
1 reference
A van Oosterom
1 reference
EORTC New Drug Development Group (NDDG)
1 reference
3 July 2006
1 reference
1 reference
42
1 reference
12
1 reference
1768-1774
1 reference
Identifiers
1 reference
1 reference